AstraZeneca reported core earnings for the fourth quarter just in need of consensus, but stated it anticipated double-digit proportion growth in 2024. Unilever posted a better-than-expected operating revenue for 2023, with underlying sales growth of 7%, and launched a buyback to start out in the second quarter. The IPO price vary is Rs 1195 to Rs 1258 per share with a face worth of Rs 10, aiming to boost Rs 1,600.00 crores. Copyright© 2024, THG PUBLISHING PVT LTD. or its affiliated firms. Southeast Bank just lately organised its “Business Review Meeting-2024” at the bank’s head office in Dhaka.
On the…